Development and In Vitro Evaluation of Standardized Mangosteen Pericarp Granules as a Candidate Feed Additive for Antibiotic-Free Poultry
Prasopchai Patrojanasophon, Nitjawan Sahatsapan, Supusson Pengnam, Boonnada Pamornpathomkul, Thapakorn Charoenying, Tanasait Ngawhirunpat, Theerasak Rojanarata, Praneet Opanasopit, and Chaiyakarn Pornpitchanarong*Anstract Antibiotic-free poultry production requires standardized and effective phytogenic alternatives to support animal health and reduce reliance on antimicrobial growth promoters. Mangosteen pericarp is rich in α-mangostin, but its direct use in feed is limited by variability, poor flowability, and handling difficulties. This study aimed to develop standardized mangosteen pericarp granules and evaluate their physical handling properties, storage stability, and in vitro antimicrobial activity against selected avian Salmonella serovars. Raw mangosteen pericarp powder was standardized by quantifying α-mangostin content using HPLC. Wet granulation was performed using different binders and concentrations, and the resulting granules were characterized for flowability and active compound content. The optimized formulation was subjected to a 6-month stability study under intermediate and accelerated conditions. Antimicrobial activity was evaluated using a broth microdilution method. The standardized raw powder contained 83.47 ± 0.95 mg/g α-mangostin, equivalent to 8.35% w/w. Granulation with 5% hydroxypropyl methylcellulose significantly improved flow characteristics by reducing the angle of repose from fair to excellent. No obvious visual changes in granule appearance were observed, and α-mangostin content was maintained over 6 months. The optimized formulation inhibited the growth of S. Pullorum, S. Enteritidis, S. Typhimurium, and S. Gallinarum, with a minimum inhibitory concentration of 0.34 mg/mL. These findings demonstrate that wet granulation can transform mangosteen pericarp powder into a standardized and stable prototype formulation with in vitro activity against selected avian Salmonella serovars. Further in vivo studies are required to confirm its efficacy and safety as a feed additive in poultry production.
Keywords: α-mangostin, Antibiotic alternative, Feed additive, Garcinia mangostana, Layers
Citation: Patrojanasophon, P., Sahatsapan, N., Pengnam, S., Pamornpathomkul, B., Charoenying, T., Ngawhirunpat, T., Rojanarata, T., Opanasopit, P., and Pornpitchanarong, C. 2027. Development and in vitro evaluation of standardized mangosteen pericarp granules as a candidate feed additive for antibiotic-free poultry. Natural and Life Sciences Communications. 26(1): e2027023.
Graphical Abstract:

INTRODUCTION
The global poultry industry is at a critical juncture, facing the dual pressures of increasing consumer demand for safe, high-quality protein and a paradigm shift away from the routine use of antibiotics. For decades, antibiotic growth promoters (AGPs) have played an important role in maintaining flock health and productivity, particularly in intensive production systems such as layer hen farming (Dibner and Richards, 2005; Khasanah et al., 2024). However, the association between the sub-therapeutic use of AGPs in livestock and the emergence of antimicrobial resistance (AMR) has led to stringent regulatory actions and bans in many countries (Castanon, 2007; Khasanah et al., 2024). Consequently, there is an urgent industry-wide need for effective, sustainable, and safe alternatives that can support animal health and performance without contributing to the global AMR burden (Aslam et al., 2024). In this context, phytogenic feed additives derived from plant extracts have gained considerable attention as promising alternatives (Van Boeckel et al., 2015). These natural compounds provide a multi-faceted approach to animal health through antimicrobial, anti-inflammatory, antioxidant, and immunomodulatory activities (Mnisi et al., 2023). For laying hens, which experience prolonged periods of high metabolic and physiological demand, these additional biological functions are particularly relevant. Beyond pathogen control, phytogenic compounds may help enhance gut integrity, improve nutrient utilization, and mitigate oxidative stress, thereby supporting flock health, longevity, and productivity in antibiotic-free production systems (Obianwuna et al., 2024).
Among the wide range of botanical resources, the pericarp of mangosteen fruit (Garcinia mangostana L.) has emerged as a promising candidate for development as a phytogenic feed additive. Although it is commonly regarded as an agricultural byproduct, mangosteen pericarp is a concentrated source of polyphenolic xanthones, with α-mangostin being the most abundant and biologically active compound (Chuapaditphun et al., 2019; Sriboonyong et al., 2022). The antimicrobial activity of α-mangostin has been well documented, and its mechanism has been associated with disruption of bacterial cytoplasmic membrane integrity, which may reduce the likelihood of resistance development compared with conventional antibiotics (Dharmaratne et al., 2013; Gutierrez-Orozco and Failla, 2013). This activity is particularly relevant to pathogens of importance in the layer industry, especially Salmonella Enteritidis, a major cause of foodborne illness in humans that can colonize the reproductive tract of laying hens and be transmitted vertically into eggs, posing both food safety risks and economic losses (Shaji et al., 2023). The reported efficacy of α-mangostin against Salmonella serovars suggests its potential as a natural agent to reduce pathogen load in the gastrointestinal tract and minimize horizontal and vertical transmission within layer flocks (Sultan et al., 2022). In addition, its antioxidant and anti-inflammatory properties may help alleviate physiological stress associated with egg production and may contribute to improved gut health and feed efficiency, which are important performance indicators in antibiotic-free poultry production (Obianwuna et al., 2024). Previous studies have also supported the practical potential of mangosteen peel extract in animal production. Herawati et al. (2020) reported that mangosteen peel extract supplementation in broiler feed improved weight gain during week 3 without adversely affecting feed conversion ratio and, importantly, did not increase antibiotic resistance, unlike conventional antibiotic growth promoters (Herawati et al., 2020). Similarly, Semangoen et al. (2025) showed that aerosolized mangosteen peel extract effectively controlled airborne bacterial and fungal contamination in swine and poultry farm environments (Semangoen et al., 2025).
Although mangosteen pericarp has shown biological potential, its development as a poultry feed ingredient requires more than evidence of antimicrobial activity from crude extracts. In addition, its unfavorable physical properties, including low bulk density, high dustiness, and poor flowability, may hinder homogeneous feed mixing and accurate dosing, resulting in inconsistent efficacy (Soontornwat et al., 2024). A standardized delivery form is necessary to ensure reproducible α-mangostin content, homogeneous distribution in feed, acceptable handling properties, and retention of bioactivity after processing. Wet granulation may improve the flow and dosing characteristics of the raw powder; however, the process may expose α-mangostin and other phytochemicals to moisture, heat, and mechanical stress, which could affect chemical stability and antimicrobial activity. Therefore, the development of a standardized, stable, and physically optimized formulation is a critical prerequisite for its successful application as a feed additive. The present study was designed to bridge the gap between raw botanical material and a viable, evidence-based poultry feed additive. The novelty of the present study therefore lies in a single formulation-development framework of integrating botanical authentication, marker-based standardization, wet-granulation optimization, storage evaluation, and in vitro anti-Salmonella assessment. The aim of this study was to transform mangosteen pericarp powder into a standardized and stable granule formulation suitable for further evaluation as a poultry feed additive. The study focused on α-mangostin standardization, wet granulation optimization, physicotechnical characterization, stability assessment, and in vitro antimicrobial testing against selected avian Salmonella serovars.
MATERIALS AND METHODS
Materials
Mangosteen (Garcinia mangostana L.) pericarp raw material was provided by Kaewmungkornphaesaj Co. Ltd, Ratchaburi, Thailand. The supplied pericarp was used as the plant material in this study and was subjected to chemical identity assessment before formulation development. An analytical reference standard of α-mangostin (purity ≥ 98% by HPLC) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Solvents for extraction and chromatography, including absolute ethanol (99.8% v/v), dichloromethane, ethyl acetate, acetone, methanol, and n-hexane, were of analytical reagent (AR) grade (Merck, Darmstadt, Germany). Ferric chloride, vanillin, concentrated sulfuric acid, silica gel 60 GF254 Thin-layer chromatography (TLC) plates, and silica gel 60 for column chromatography were also sourced from Merck (Darmstadt, Germany). Ortho-phosphoric acid (AR grade) was used for mobile phase preparation.
Plant material preparation and physicochemical standardization
The mangosteen (Garcinia mangostana L.) pericarp raw material was obtained from Kaewmungkornphaesaj Co. Ltd, Ratchaburi, Thailand. To confirm the identity and quality of the raw material, the mangosteen pericarp powder was subjected to a series of chemical identification tests to ascertain the identity of the material.
Ferric chloride test for phenolic compounds
A sample of the powder (500 mg) was boiled with 10 mL of distilled water on a water bath for 5 min and subsequently filtered. To 1 mL of the filtrate, 2–3 drops of ferric chloride test solution were added. A positive result, indicated by the formation of a distinct brownish-green precipitate, confirmed the presence of phenolic compounds (Ngameni et al., 2013).
Vanillin-sulfuric acid test for tannins/flavonoids
An aqueous extract was prepared as described above. A 5 mL aliquot of the filtrate was evaporated to dryness in an evaporating dish. The resulting residue was then treated with 2–3 drops of freshly prepared vanillin-sulfuric acid reagent (5% w/v vanillin in concentrated H₂SO₄). The immediate development of a red color was considered a positive test (Le et al., 2018).
Thin-layer chromatography analysis
TLC was employed to confirm the presence of the principal active compound, α-mangostin, in the powder (Sriboonyong et al., 2022). A test solution was prepared by extracting 100 mg of the pericarp powder with 1 mL of 95% ethanol on a water bath for 5 min. The mixture was centrifuged, and the supernatant was used for analysis. A standard solution of α-mangostin was prepared in 95% ethanol. Silica gel GF254 TLC plate (20 cm x 20 cm) was used as the stationary phase, while the mobile phase was chloroform:ethyl acetate (85:15, v/v). A 20 μL of the test solution was applied as a 10 mm band onto the plate. The α-mangostin standard was applied to an adjacent lane. After development, the plate was air-dried and examined under UV light at 254 nm. For chemical derivatization, the plate was sequentially sprayed with a 2% (w/v) vanillin in methanol solution, followed by a 10% (v/v) sulfuric acid in methanol solution. The presence of α-mangostin in the sample was confirmed by the appearance of a distinct yellow band at an Rƒ value identical to that of the α-mangostin standard.
Development of α-mangostin working standard
To establish a reliable quantitative reference, α-mangostin was isolated from the crude pericarp extract. The purification was achieved using preparative column chromatography, and the isolated compound was subsequently used to develop a standard curve for the quantification of α-mangostin in the raw material and final product formulation.
Preparation of crude extract
One gram of dried mangosteen pericarp powder was extracted with 15 mL of dichloromethane. The mixture was thoroughly agitated and subsequently filtered through Whatman No. 1 filter paper to remove insoluble plant material. The resulting filtrate, containing the crude extract of xanthones, was used directly for chromatographic separation.
Column chromatography and fractionation
The crude extract was purified by silica gel column chromatography (Sriboonyong et al., 2022). The separation was performed on a glass column (2 × 30 cm) wet-packed with 50 g of silica gel using a dichloromethane:hexane (4:6, v/v) slurry to a final bed height of 30 cm. After loading the extract, the column was subjected to a step-gradient elution. Initially, an isocratic elution was performed with dichloromethane:hexane (4:6, v/v). The first 400 mL of eluent was discarded, after which fractions were collected at varying volumes: 100 mL (fractions 1–5) and 50 mL (fractions 6–20). The mobile phase polarity was then increased to dichloromethane: hexane (6:4, v/v), and collection continued with 25 mL (fractions 21–30) and 10 mL aliquots (fractions 31–140). All collected fractions were reserved for subsequent analysis to identify and pool those containing purified α-mangostin. The presence of α-mangostin was monitored using a TLC plate in which chloroform: ethyl acetate (85:15) was used as mobile phase. The spots were visualized under UV light at 254 and 366 nm.
HPLC instrumentation and chromatographic conditions
Quantitative analysis was performed on a High-Performance Liquid Chromatography (HPLC) system equipped with a UV detector (Sriboonyong et al., 2022). The chromatographic separation was achieved on a ReproSil-Pur Basic C18 column (250 mm × 4.6 mm, 5 µm particle size) maintained at 25°C. The mobile phase consisted of acetonitrile (solvent A) and 0.1% (v/v) aqueous ortho-phosphoric acid (solvent B). A gradient elution program was employed at a flow rate of 1.0 mL/min as follows: 0-15 min, 70% A; 15-18 min, linear gradient from 70% to 75% A; 18-19 min, linear gradient from 75% to 80% A; 19-25 min, 80% A; 25-26 min, linear gradient from 80% to 70% A. The injection volume was 20 µL, and detection was performed at a wavelength of 320 nm. A stock solution of the isolated α-mangostin was prepared in methanol. This was serially diluted to prepare working standard solutions at concentrations of 50–250 µg/mL. Each concentration was injected into the HPLC system (n=5). A calibration curve was constructed by plotting the mean peak area against the corresponding concentration of α-mangostin.
Optimization of the extraction method for quantification
To establish an optimal extraction procedure for routine quality control, four different solvent systems were evaluated for their efficiency in extracting α-mangostin. For water extraction (decoction), 1 g of pericarp powder was boiled with 20 mL of distilled water for 10 min. The residue was re-extracted with another 10 mL of water under the same conditions. The filtrates were combined and evaporated to dryness. For ethanol extraction (maceration), 1 g of pericarp powder was macerated with 6 mL of either 50%, 70%, or absolute ethanol at room temperature for 24 h. The residue was re-extracted with an additional 6 mL of the respective solvent for another 24 h. The combined filtrates for each solvent concentration were evaporated to dryness at 50°C. All resulting dried extracts were reconstituted and analyzed for α-mangostin content using the HPLC method described above to determine the most effective extraction solvent.
Quantification of α-mangostin in standardized pericarp powder
Based on the results of the extraction optimization, a standardized protocol was established for the quantification of α-mangostin in the mangosteen pericarp powder. An accurately weighed sample of pericarp powder (1 g) was subjected to exhaustive maceration with absolute ethanol (2 × 6 mL), with each extraction period lasting 24 h. The combined ethanolic extracts were filtered, evaporated to dryness at 50°C, and the residue was appropriately diluted for HPLC analysis. The α-mangostin content was calculated using the regression equation from the calibration curve and expressed as a percentage by weight of the initial dried powder using the Equation (1).

Where, C is the α-mangostin concentration obtained from the calibration curve, in mg/mL, V is the final volume of the sample solution (mL), DF is the dilution factor, and W is the weight of dried pericarp powder extracted (g).
Formulation of mangosteen pericarp granules
To improve the physical properties of the mangosteen pericarp powder for application in animal feed, a wet granulation technique was employed. Nine formulations (F1–F9) were prepared to evaluate the effects of different binders and concentrations. The binders investigated were hydroxypropyl methylcellulose (HPMC), polyvinylpyrrolidone K30 (PVP K30), and polyvinylpyrrolidone K90 (PVP K90), each at concentrations of 1%, 3%, and 5% (w/w).
For each formulation, a 10 g batch was prepared. The required amount of binder was first dissolved in 15 mL of purified water to create a binder solution. The standardized mangosteen pericarp powder was then placed in a mixing bowl, and the binder solution was gradually added under continuous mixing to form a homogenous, cohesive wet mass. This wet mass was spread onto a stainless-steel tray and dried in a hot air oven at 50°C until the moisture content was sufficiently low. Finally, the dried granules were passed through a 0.85 mm sieve (Mesh No. 20) to obtain uniform particles. The composition of each formulation is detailed in Table 1. Product yield was calculated as the percentage of the recovered dry granule weight relative to the initial total dry weight of pericarp powder and binder using the Equation (2).

Table 1. Composition of mangosteen pericarp granule formulations.
|
Formulation |
Binder type |
Binder Conc. (% w/w) |
Weight of binder (g) |
Weight of pericarp powder (g) |
Volume of water (mL) |
|
F1 |
HPMC |
1 |
0.1 |
9.9 |
15 |
|
F2 |
HPMC |
3 |
0.3 |
9.7 |
15 |
|
F3 |
HPMC |
5 |
0.5 |
9.5 |
15 |
|
F4 |
PVP K30 |
1 |
0.1 |
9.9 |
15 |
|
F5 |
PVP K30 |
3 |
0.3 |
9.7 |
15 |
|
F6 |
PVP K30 |
5 |
0.5 |
9.5 |
15 |
|
F7 |
PVP K90 |
1 |
0.1 |
9.9 |
15 |
|
F8 |
PVP K90 |
3 |
0.3 |
9.7 |
15 |
|
F9 |
PVP K90 |
5 |
0.5 |
9.5 |
15 |
Characterization of mangosteen pericarp granules
Evaluation of flow properties
The flowability of the granules was assessed by determining the angle of repose (θ) using the adapted cylinder-lift method (Ghosh et al., 2012). Approximately 5 g of each granular formulation was carefully poured through a hollow cylinder (modified from a 50 mL tube, open at both ends) placed vertically onto a flat surface. The cylinder was then lifted vertically, allowing the powder to form a conical pile. The height (h) and the diameter (d) of the resulting cone were measured. The angle of repose was calculated using the Equation 3.
θ = tan⁻¹(h / (0.5d)) (3)
terial suspension was adjusted with sterile broth to match a 0.5 McFarland standard and then further diluted to achieve a final working inoculum of approximately 1 × 10⁶ CFU/mL.
Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
The MIC was determined using the broth microdilution method in 24-well plates. The granular formulation was serially diluted in the appropriate broth to achieve a range of final concentrations from 0.02 to 10.88 mg/mL. Before antimicrobial testing, the granule formulation was dispersed in sterile broth and vortexed for 30 min to obtain a uniform stock dispersion. The dispersion was centrifuged at 4000 rpm for 10 min to reduce coarse insoluble particles. A blank broth was included as negative control. Gentamycin (50 µg/mL) was used as a positive antimicrobial control.
Serial dilutions were prepared from the supernatant. An aliquot (10 µL) of the standardized bacterial inoculum was added to each well. The plates were incubated at 37°C for 24 h. The MIC was defined as the lowest concentration of the formulation that completely inhibited visible bacterial growth, as compared to the drug-free control.
To determine the MBC, a 100 µL aliquot was taken from all visually clear wells from the MIC determination test and spread onto the surface of the corresponding agar plates. The plates were incubated at 37°C for 24 h. The MBC was defined as the lowest concentration of the formulation that resulted in no colony growth on the agar plate, indicating ≥99.9% killing of the initial inoculum. All antimicrobial experiments were performed in triplicate.
Statistical analysis
Data are presented as mean ± standard deviation (SD). All experiments were performed at least in triplicate unless otherwise stated. Statistical analysis was performed using SPSS® software version 19 (SPSS Inc., Chicago, IL, USA). Differences among multiple groups were analyzed using one-way analysis of variance (ANOVA), followed by Tukey’s post hoc test. A p-value of <0.05 was considered statistically significant.
RESULTS
Identification, purification, and standardization
The mangosteen pericarp powder underwent a series of qualitative and quantitative analyses to establish its identity and facilitate quality control. The identity of mangosteen pericarp powder was confirmed using qualitative phytochemical tests and TLC analysis. The ferric chloride test produced a brownish-green precipitate, indicating the presence of phenolic compounds. The vanillin-sulfuric acid test produced a red color, suggesting the presence of terpenoids or flavonoids. TLC provided direct evidence of the target bioactive, α-mangostin. The chromatogram of the ethanol extract revealed a distinct spot with an Rf value matching the α-mangostin reference standard.
For qualitative analysis, α-mangostin working standard was isolated via silica gel column chromatography. Elution monitoring identified fractions #90 through #140 as containing the target compound (Figure 1). Subsequent HPLC analysis showed that fractions from fraction 96 onward contained a major peak with a retention time corresponding to that of the commercial α-mangostin reference standard, supporting the presence of α-mangostin in the isolated material (Figure 2). The chromatograms were used for qualitative retention-time comparison. Because the concentration of the isolated fraction was not determined before injection, its peak area was not directly compared with that of the commercial standard. The isolated fraction was subsequently used as an in-house working standard for formulation development and comparative quantification. A five-point calibration curve was constructed over the concentration range of 50–250 µg/mL, yielding the regression with a coefficient of determination of R² = 0.9994 (Figure 3).

Figure 1. TLC chromatogram of fractions collected from column chromatography. Lane 1: α-mangostin standard; Lanes 2-16: Fractions #1, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, and 140, respectively.

Figure 2. Representative HPLC chromatograms used for qualitative identity confirmation of α-mangostin: (a) commercial α-mangostin reference standard at 100 µg/mL and (b) isolated column chromatography fraction #96.

Figure 3. Calibration curve of α-mangostin over the concentration range of 50–250 µg/mL. Each point represents the mean peak area ± SD of five injections.
Optimization of the α-mangostin extraction procedure
To ensure the potency of the raw material was accurately measured, the solvent extraction procedure was systematically optimized. The extraction efficiency of water and different ethanol concentrations was compared for α-mangostin quantification. As shown in Table 2, α-mangostin was not detected in the water extract. In contrast, ethanolic extraction yielded detectable α-mangostin, and the measured content increased with ethanol concentration. The highest α-mangostin content was obtained using absolute ethanol, followed by 70% and 50% ethanol. Based on this result, absolute ethanol was selected for subsequent quantification of α-mangostin in mangosteen pericarp powder. The standardized powder contained 83.47 ± 0.95 mg/g α-mangostin, corresponding to 8.35% w/w.
Table 2. Yield of α-mangostin from mangosteen pericarp powder using different extraction solvents.
|
Extraction solvent |
α-Mangostin content (mg/g of powder) |
|
Water |
Not Detected |
|
50% Ethanol |
76.62 ± 0.68 |
|
70% Ethanol |
78.53 ± 1.80 |
|
Absolute ethanol |
83.47 ± 0.95 |
Formulation of mangosteen pericarp granules
A significant barrier to the commercial application of raw mangosteen pericarp powder is its poor physicotechnical properties, characterized by fine, cohesive particles, high inter-particulate friction, and poor flowability. These traits hinder uniform mixing in feed and pose occupational hazards. To address these limitations, nine mangosteen pericarp granule formulations, F1–F9, were prepared by wet granulation using HPMC, PVP K30, or PVP K90 at concentrations of 1%, 3%, and 5% w/w. The physical appearance of the formulations is shown in Table 3. Formulations containing 1% or 3% binder showed incomplete granulation, with friable particles and visible residual fine powder. In contrast, formulations containing 5% binder, particularly F3, F6, and F9, produced more coherent granules with fewer fine particles. Among these, F3 and F9 showed the most uniform granule appearance and minimal adhesion to the container wall. Product yields were above 90% for all formulations.
Table 3. Characteristics of the mangosteen pericarp powder formulation.

Evaluation of granule properties
Flowability
To quantitatively assess improvements in handling characteristics, the flowability of each formulation was interpreted using Carr’s classification based on the measured angle of repose (Table 4). The unformulated mangosteen pericarp powder showed an angle of repose of 43.37 ± 1.29°, corresponding to passable flowability. Wet granulation improved the flow properties of all formulations. Formulations F1, F2, and F4–F8 showed angles of repose between 30° and 33° and were classified as having good flowability. F3 and F9 showed the lowest angles of repose, 28.05 ± 1.78° and 28.31 ± 1.44°, respectively, and were classified as having excellent flowability.
Table 4. Effect of different binders and concentrations on the physical properties and flow characteristics of mangosteen pericarp powder formulations.
|
Formulation |
Binder composition |
Angle of repose (°) |
Flow property classification |
|
Control |
None (Unformulated Powder) |
43.37 ± 1.29 |
Passable |
|
F1 |
1% w/w HPMC |
31.50 ± 0.87 |
Good (Free flowing) |
|
F2 |
3% w/w HPMC |
30.00 ± 0.87 |
Good (Free flowing) |
|
F3 |
5% w/w HPMC |
28.05 ± 1.78 |
Excellent |
|
F4 |
1% w/w PVP K30 |
30.00 ± 0.87 |
Good (Free flowing) |
|
F5 |
3% w/w PVP K30 |
31.50 ± 0.87 |
Good (Free flowing) |
|
F6 |
5% w/w PVP K30 |
31.65 ± 1.65 |
Good (Free flowing) |
|
F7 |
1% w/w PVP K90 |
33.40 ± 1.61 |
Good (Free flowing) |
|
F8 |
3% w/w PVP K90 |
31.50 ± 1.87 |
Good (Free flowing) |
|
F9 |
5% w/w PVP K90 |
28.31 ± 1.44 |
Excellent |
Active compound content and final formulation selection
α-Mangostin content was determined after granulation to evaluate whether the wet granulation process affected the measurable active compound content. As shown in Figure 4, the measurable α-mangostin content differed among formulations. Formulations F3, F6, and F9, all containing 5% binder, showed higher measurable α-mangostin content than other formulations of the same binder (P < 0.05). These findings suggested that the granulation process did not reduce the detectable α-mangostin content. Based on the combined evaluation of granule appearance, flowability, and α-mangostin recovery, F3 was selected as the optimized formulation for subsequent stability and antimicrobial evaluations. Although F6 showed comparable α-mangostin recovery, it was not selected because its flowability was less favorable than that of F3. F9 also showed excellent flowability and high α-mangostin recovery; however, visual inspection indicated greater apparent variation in granule size and less homogeneous granule formation. Therefore, F3 was considered to provide the most balanced overall formulation profile.

Figure 4. Quantification of α-mangostin in the unformulated mangosteen pericarp powder and granulated formulations. Data are presented as mean ± SD (n = 3). The asterisk (*) indicates statistically significant differences among formulations across the same binder (P < 0.05).
Stability study
The selected formulations were evaluated for 6 months under intermediate and accelerated storage conditions to determine whether the main formulation attributes were maintained. Visual observation showed no obvious changes in color, caking, hardening, or visible loss of granule integrity after storage under either condition (Figure 5). These observations indicated that the granules retained their general physical appearance during the storage period. The α-mangostin content of the stored samples is shown in Figure 6. No statistically significant reduction in α-mangostin content was observed after 3 months under either storage condition. After 6 months, slight variations in mean α-mangostin content were observed in some samples, especially F6 (P < 0.05) in both storage temperatures; however, other formulations were not statistically significant (P > 0.05). These results indicated that the selected granule formulations maintained the α-mangostin content during the 6-month storage period.

Figure 5. Physical appearance of the unformulated mangosteen pericarp powder and granule formulations after storage at (a) 30 ± 2 °C/75 ± 5% RH for 3 months; (b) 40 ± 2 °C/75 ± 5% RH for 3 months; (c) 30 ± 2 °C/75 ± 5% RH for 6 months; and (d) 40 ± 2 °C/75 ± 5% RH for 6 months.

Figure 6. Chemical stability of α-mangostin in granulated mangosteen pericarp formulations (F3, F6, and F9) and unformulated powder (Control) over a 6-month period. The α-mangostin content was quantified at 0, 3, and 6 months for samples stored under intermediate conditions (30 ± 2 °C, 75 ± 5% RH) and accelerated conditions (40 ± 2 °C, 75 ± 5% RH).
In vitro antimicrobial efficacy against avian Salmonella serovars
To validate the biological activity of the final product, the in vitro antimicrobial activity of the optimized formulation was evaluated against four avian Salmonella serovars using the broth microdilution method. F3 inhibited visible growth of all tested serovars at 0.34 mg/mL. Therefore, the MIC of F3 was 0.34 mg/mL for S. Pullorum, S. Enteritidis, S. Typhimurium, and S. Gallinarum.
The MBC values differed among the tested serovars. The lowest MBC was observed for S. Pullorum at 0.68 mg/mL. The MBC values for S. Enteritidis and S. Typhimurium were 1.36 mg/mL, while S. Gallinarum showed the highest MBC value at 5.44 mg/mL. These results indicate that the formulation showed inhibitory activity against the tested avian Salmonella serovars, with serovar-dependent differences in antimicrobial efficacy.
DISCUSSION
Phytochemical standardization
The development of a reliable phytogenic product requires appropriate authentication and standardization of the botanical raw material (World Health Organization, 2011). In the present study, the ferric chloride and vanillin–sulfuric acid reactions supported the presence of phenolic constituents and other reactive phytochemical groups in the mangosteen pericarp matrix. The positive ferric chloride reaction was consistent with the polyphenolic structure of xanthones, while the vanillin–sulfuric acid reaction provided additional qualitative evidence of phytochemical constituents in the raw material. Mangosteen pericarp contains several xanthones in addition to α-mangostin, including β-mangostin, γ-mangostin, garcinone derivatives, and other related polyphenolic compounds. Tannins, flavonoids, and other phenolic constituents may also contribute to its overall chemical profile and biological activity (Le et al., 2018; Sun and Shahrajabian, 2023). Therefore, α-mangostin was selected as a quantitative marker for standardization in this study rather than being considered the sole biologically active constituent of mangosteen pericarp. This approach provided a practical basis for comparing the raw material, granulated formulations, and stored samples while acknowledging the chemically complex nature of the botanical matrix (Bi et al., 2023; Karim et al., 2024).
The successful isolation and purification of an in-house working standard represent a critical and pragmatic achievement. While commercially available certified reference materials (CRMs) are the gold standard, their high cost can be prohibitive for routine quality control and extensive experimental work (Ermer, 2001). Establishing a well-characterized working standard calibrated against a primary CRM is an accepted practice in pharmaceutical analysis that ensures the validity and reproducibility of quantitative data. This approach provided a sustainable means for repeated analyses necessary for formulation, stability testing, and batch-to-batch consistency checks. Additionally, isolating the standard from the same source material provides an intimate understanding of the matrix, which aided in troubleshooting analytical methods. The exceptionally high R2 value indicated an approximately linear response over the tested concentration range (Lin et al., 2014). Although TLC and HPLC comparison with a commercial α-mangostin standard supported the identity of the isolated fraction, structural confirmation by NMR was not performed. Therefore, the isolated material was treated as an in-house working standard for routine quantification rather than as a fully characterized certified reference material. Future studies should include NMR or LC-MS confirmation to strengthen structural verification.
Solvent optimization and α-mangostin quantification
The optimization of the extraction process is of significant practical importance. An inefficient extraction would lead to an underestimation of the active compound, resulting in inaccurate product formulation and potentially misleading efficacy data. The failure of water to extract the target compound was consistent with the known chemical properties of xanthones, which are lipophilic compounds with poor aqueous solubility (Auranwiwat et al., 2026). This observation was likely governed by the fundamental principle of like dissolves like, dictating that solvent-solute affinity is maximized when polarities are closely matched (Mazzini and Craig, 2018). α-Mangostin consists of a large, rigid, and lipophilic tricyclic aromatic system, which renders it poorly soluble in highly polar solvents like water. The strong intermolecular hydrogen bonding network of water molecules cannot be effectively disrupted by the nonpolar xanthone backbone, leading to negligible extraction yields (Yuvanatemiya et al., 2022; Majdalawieh et al., 2025).
Conversely, ethanol is an amphipathic solvent possessing both a polar hydroxyl (-OH) group and a nonpolar ethyl (-CH2CH3) tail. This dual nature allowed it to interact favorably with both the polar hydroxyl groups and the nonpolar aromatic rings of the α-mangostin molecule, effectively disrupting the plant cell matrix and solvating the compound (Aparamarta et al., 2025). The observed increase in extraction efficiency from 50% to absolute ethanol further validates this principle. As the concentration of water decreases, the overall polarity of the solvent system was reduced, making it progressively more compatible with the predominantly lipophilic α-mangostin. The selection of ethanol was also a practical option for further development process. Although dichloromethane is effective for extracting xanthones and was used in this study for preparative isolation of α-mangostin, it is less suitable for routine extraction of materials intended for consumption because of toxicity and solvent-residue concerns. Ethanol provides a safer and more acceptable alternative while retaining sufficient capacity to extract the lipophilic α-mangostin molecule. This finding aligned with previous studies identifying moderately polar to nonpolar solvents as optimal for extracting xanthones from mangosteen pericarp (Obolskiy et al., 2009; Mohammad et al., 2019).
A major challenge hindering the widespread adoption of phytogenics in animal nutrition is the inherent variability of active compounds in raw plant materials due to geography, harvest time, and processing methods. Quantification showed that the mangosteen pericarp powder used in this study contained 8.35% w/w α-mangostin. This measured value provided a batch-specific reference for formulation calculations and comparison of α-mangostin recovery after granulation and storage. This measurement provided a defined starting value for formulation development and comparison within the batch evaluated in this study. This would allow the calculation of dosing when incorporating the final product into animal feed (Abdelli et al., 2021). With a standardized raw material, the formulation development phase could confidently proceed, knowing that any observed differences in the performance of the granulated products would be attributable to the formulation excipients and processing parameters, rather than fluctuations in the initial potency of the mangosteen pericarp.
Mechanics of granulation and physicotechnical enhancement
The efficacy of the wet granulation strategy is rooted in the fundamental mechanics of particle agglomeration. During the process, the binder solution forms liquid bridges between primary particles. Subsequent drying removed the solvent leaving solid bridges of solidified binder that lock particles into stable agglomerates (Shanmugam, 2015). The failure of 1% and 3% binder concentrations suggested these levels were insufficient to form a continuous and robust network of bridges throughout the powder bed, leading to weak granules unable to withstand mechanical handling stresses. The success of the 5% formulations indicated a critical threshold for binder concentration, where the polymer was present in sufficient quantity to effectively coat and bind the primary pericarp particles into durable granules (Thiengnoi et al., 2012). HPMC is a nonionic cellulose ether containing methoxy and hydroxypropoxy substituents. When dispersed in water, its polymer chains hydrate and produce a viscous binder solution capable of forming liquid bridges between powder particles. During drying, these bridges are converted into solid polymeric bonds that support granule cohesion. At 5% w/w, HPMC produced cohesive granules with fewer fines and excellent flowability. The superior performance of PVP K90 over PVP K30 (F6) was directly attributed to its higher molecular weight. The K-value of povidone correlated with its average molecular weight dictated the viscosity of the binder solution and the ultimate strength of the solid bridges formed upon drying. Higher molecular weight polymers like PVP K90 create stronger, more resilient intermolecular bonds, resulting in harder and less friable granules compared to lower molecular weight counterparts like PVP K30 (Brubaker and Moghtadernejad, 2024). Ensuring a homogeneous distribution of a feed additive is critical to preventing under-dosing or over-dosing (Lillehoj et al., 2018). The successful development of F3 and F9 represented a critical step in translating the phytogenic potential of mangosteen pericarp into a safe, reliable, and effective product for the feed industry.
The significant improvement in flow properties following granulation was possibly attributed to the increase in effective particle size and the creation of more spherical agglomerates (Lourith and Kanlayavattanakul, 2011). This structural change reduces the surface area-to-volume ratio and minimizes cohesive forces, such as van der Waals interactions, between particles. Achieving superior flowability, as seen in F3 and F9, was essential for ensuring uniform dosing and homogeneous distribution when the additive was mixed into large batches of animal feed (Hazlett et al., 2021). The present characterization focused on angle of repose and visual granule formation because improved flow and handling were the primary formulation objectives. Carr index, Hausner ratio, particle-size distribution, morphology, and chemical compatibility with the binders were not evaluated. Therefore, the findings presented as preliminary evidence of improved flow and retained α-mangostin content rather than a complete micromeritic or compatibility assessment. Future interaction studies, e.g., FTIR, DSC, may also be included to ascertain the factor affecting the physicochemical properties or biological activity of the active compounds.
Bioactive integrity and formulation stability
The α-mangostin content of the granulated formulations was slightly lower than that of the unformulated pericarp powder, which was expected because the binders accounted for up to 5% of the total dry formulation mass. The measured values were generally consistent with this dilution effect, indicating that wet granulation did not cause a substantial loss of detectable α-mangostin under the tested processing conditions. Together with the improved flow properties, retention of the active compound content supported the selection of the 5% binder formulations for further stability assessment and antimicrobial evaluation.
The stability assessment in this study was designed to confirm retention of the key formulation attributes that justified granulation. The selected formulations retained their general visual appearance and measurable α-mangostin content during the 6-month storage period. Minor variation was observed among formulations and storage conditions, with a significant reduction detected for F6 after 6 months. The overall data indicated that the granulation process, particularly with HPMC as a binder, yields a rather more stable product (Wewers et al., 2022). Because water content, or moisture uptake, and quantitative flow properties were not evaluated during storage, the findings should not be interpreted as a comprehensive demonstration of physical or commercial stability. These parameters should be included in future expanded stability studies.
Antimicrobial validation as an antibiotic alternative
The MIC results showed that the optimized granule formulation inhibited visible growth of all tested avian Salmonella serovars. The MBC values varied among serovars, indicating serovar-dependent differences in susceptibility to the formulation. Overall, the results suggested that the granulated mangosteen pericarp formulation maintained measurable in vitro antimicrobial activity of its parent material and supports further investigation as a candidate phytogenic feed ingredient (Yazarlu et al., 2021; Zhu et al., 2024).
The uniform MIC of 0.34 mg/mL suggested a consistent inhibitory activity against the tested Salmonella serovars. Many plant-derived polyphenols, specifically α-mangostin, are known to exert antimicrobial effects by disrupting bacterial cytoplasmic membrane integrity, inhibiting crucial enzymes, or interfering with cellular energy metabolism (Ibrahim et al., 2014; Ge et al., 2024). The ability to inhibit diverse serovars at a consistent, low concentration is particularly significant, as these pathogens cause economically devastating diseases in poultry, leading to decreased egg production, increased morbidity, and higher mortality rates (Andreatti Filho et al., 2019; Shaji et al., 2023). In the intestinal lumen of a layer hen, the therapeutic goal is often not complete gut sterilization, but rather the control of pathogenic Salmonella spp. proliferation to a level that does not overwhelm the host’s immune system (Lillehoj et al., 2018). By suppressing pathogenic growth, the formulation may shift the gut microbial balance in favor of beneficial commensal bacteria, thereby enhancing gut health and integrity. The present findings also complement previous in vivo reports on mangosteen pericarp extract in poultry. Kaewtui et al. (2024) reported that dietary mangosteen pericarp extract showed safety and immunomodulatory potential in chickens. Thus, the present study presented its in vitro inhibitory activity against selected avian Salmonella serovars (Kaewtui et al., 2024). Together, these findings support further in vivo evaluation. One limitation of the antimicrobial evaluation is that only one ATCC reference strain per serovar was tested. Therefore, the results should be interpreted as preliminary evidence of inhibitory activity against standardized reference strains rather than as representative susceptibility data for the broader population of each serovar. Future studies should include multiple poultry-derived field isolates from different sources to evaluate variability, robustness, and practical relevance of the antimicrobial effect, as well as, determining efficacy, safety, dosage, and practical relevance in poultry production.
An effective feed additive capable of controlling these zoonotic pathogens at the farm level represented an intervention for protecting both animal welfare and human food safety. These results provide a supporting evidence for using this standardized, granulated mangosteen pericarp as a candidate phytogenic approach that warrants further in vivo evaluation. By targeting the most relevant Salmonella pathogens threatening the industry, the formulation has the potential to mitigate economic losses and decrease the burden of foodborne pathogens entering the human food chain (European Food Safety Authority, 2023).
Mangosteen pericarp contains naturally colored xanthones and other phenolic constituents that may affect the appearance of the feed. Previous in vivo studies on mangosteen pericarp extract in poultry has no reports on its color affecting meat and egg production. Kaewtui et al. (2024) reported dietary safety and immunomodulatory potential in chickens, while Sriboonyong et al. (2022) evaluated standardized mangosteen pericarp extract in broilers without reporting color-related adverse effects (Sriboonyong et al., 2022; Kaewtui et al., 2024). However, possible effects on feed acceptance, tissue pigmentation, eggshell color, and egg-yolk color remain uncertain and should be evaluated in future poultry studies.
CONCLUSION
This study demonstrated the successful development of standardized mangosteen pericarp granules as a candidate phytogenic feed additive for potential application in antibiotic-free poultry production. The raw mangosteen pericarp powder was standardized based on α-mangostin content. Wet granulation effectively addressed the major physicotechnical limitations of the raw powder, particularly poor flowability and dustiness, which are important barriers to homogeneous mixing and accurate dosing in feed manufacturing. Among the tested formulations, granules prepared with 5% HPMC showed favorable physical characteristics, excellent flowability, and acceptable α-mangostin recovery. The optimized formulation showed no obvious visual changes and generally retained measurable α-mangostin content over 6 months under intermediate and accelerated storage conditions, indicating the suitability of the granulation approach for improving product stability. In addition, the formulation exhibited in vitro inhibitory activity against selected avian Salmonella serovars, including S. Pullorum, S. Enteritidis, S. Typhimurium, and S. Gallinarum, with a consistent MIC of 0.34 mg/mL. These findings support the potential of standardized mangosteen pericarp granules as a promising candidate for further development as a candidate phytogenic feed ingredient in poultry feed. However, in vivo studies in poultry are still required to confirm the optimal dosage, safety, efficacy, effects on gut health and production performance.
ACKNOWLEDGEMENT
This research project was financially supported by the Agricultural Research Development Agency (Public Organization) (Grant No. CRP6305031830). We would also like to acknowledge the Faculty of Pharmacy, Silpakorn University for facility supports.
AUTHOR CONTRIBUTIONS
Prasopchai Patrojanasophon: Conceptualization (Equal), Methodology (Equal), Formal Analysis (Equal), Writing – Original Draft (Lead), Supervision (Equal), Funding Acquisition (Lead); Nitjawan Sahatsapan: Investigation (Equal), Data Curation (Equal); Supusson Pengnam: Investigation (Equal), Data Curation (Equal); Boonnada Pamornpathomkul: Investigation (Equal), Data Curation (Equal), Project Administration (Lead); Thapakorn Charoenying: Investigation (Equal), Data Curation (Equal); Tanasait Ngawhirunpat: Conceptualization (Equal), Methodology (Equal), Supervision (Equal); Theerasak Rojanarata: Methodology (Equal), Validation (Lead), Visualization (Supporting); Praneet Opanasopit: Conceptualization (Equal), Methodology (Equal), Resources (Lead), Supervision (Equal); Chaiyakarn Pornpitchanarong: Conceptualization (Equal), Methodology (Equal), Formal Analysis (Equal), Investigation (Equal), Visualization (Lead), Writing – Review & Editing (Lead).
DATA AVAILABILITY
All data supporting the findings of this study are available within the paper.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest.
REFERENCES
Abdelli, N., Sola-Oriol, D., and Perez, J.F. 2021. Phytogenic feed additives in poultry: Achievements, prospective and challenges. Animals. 11(12): 3471. https://doi.org/10.3390/ani11123471
Andreatti Filho, R.L., Milbradt, E.L., Okamoto, A.S., Silva, T.M., Vellano, I.H.B., Gross, L.S., Oro, C.S., and Hataka, A. 2019. Salmonella enteritidis infection, corticosterone levels, performance and egg quality in laying hens submitted to different methods of molting. Poultry Science. 98(10): 4416-4425. https://doi.org/10.3382/ps/pez248
Aparamarta, H.W., Sanjaya, M.R., Azimatarrusydi, R., Nanta, T.L., Widjaja, A., and Chan, M.W.Y. 2025. Optimization of α-mangostin and catechins compound extraction from mangosteen skin extract (Garcinia mangostana L.) as potential antioxidant using combination method of microwaved assisted extraction - batchwise solvent extraction. South African Journal of Chemical Engineering. 54: 191-199. https://doi.org/10.1016/j.sajce.2025.07.013
Aslam, B., Asghar, R., Muzammil, S., Shafique, M., Siddique, A.B., Khurshid, M., Ijaz, M., Rasool, M.H., Chaudhry, T.H., Aamir, A., et al. 2024. AMR and sustainable development goals: At a crossroads. Globalization and Health. 20(1):73. https://doi.org/10.1186/s12992-024-01046-8
Auranwiwat, C., Intama, N., Limtharakul, T., Pinthong, M., Sumsakul, W., and Pyne, S. 2026. A comparison of extraction methods on α-mangostin yield, total phenolic and flavonoid content and antioxidant activity in Garcinia mangostana Linn. Natural and Life Sciences Communications. 25(1): e2026019. https://doi.org/10.12982/NLSC.2026.019
Bi, C., Xu, H., Yu, J., Ding, Z., and Liu, Z. 2023. Botanical characteristics, chemical components, biological activity, and potential applications of mangosteen. PeerJ. 11: e15329. https://doi.org/10.7717/peerj.15329
Brubaker, J. and Moghtadernejad, S. 2024. A comprehensive review of the rheological properties of powders in pharmaceuticals. Powders. 3(2): 233-254. https://doi.org/10.3390/powders3020015
Castanon, J.I. 2007. History of the use of antibiotic as growth promoters in European poultry feeds. Poultry Science. 86(11): 2466-2471. https://doi.org/10.3382/ps.2007-00249
Chuapaditphun, P., Kajhonlit, B., Panyakawin, S., and Wannachaiyasit, S. 2019. Development of cream formulation containing Tetragonula pagdeni propolis from mangosteen orchards and evaluation of antibacterial activity against Staphylococcus aureus. Thai Bulletin of Pharmaceutical Sciences. 14(2): 93-103. https://doi.org/10.69598/tbps.14.2.93-103
Dharmaratne, H.R., Sakagami, Y., Piyasena, K.G., and Thevanesam, V. 2013. Antibacterial activity of xanthones from Garcinia mangostana (L.) and their structure-activity relationship studies. Natural Product Research. 27(10): 938-941. https://doi.org/10.1080/14786419.2012.678348
Dibner, J.J. and Richards, J.D. 2005. Antibiotic growth promoters in agriculture: History and mode of action. Poultry Science. 84(4): 634-643. https://doi.org/10.1093/ps/84.4.634
Ermer, J. 2001. Validation in pharmaceutical analysis. Part I: An integrated approach. Journal of Pharmaceutical and Biomedical Analysis. 24(5-6): 755-767. https://doi.org/10.1016/S0731-7085(00)00530-6
European Food Safety Authority. 2023. Plain language summary on the European union one health 2022 zoonoses report. EFSA Journal. 21(12): p211202. https://doi.org/10.2903/j.efsa.2023.p211202
Ge, R., Zhao, H., Tang, Q., Chandarajoti, K., Bai, H., Wang, X., Zhang, K., Ye, W., Han, X., Wang, C., et al. 2024. A novel alpha-mangostin derivative synergistic to antibiotics against MRSA with unique mechanisms. Microbiology Spectrum. 12(12): e0163124. https://doi.org/10.1128/spectrum.01631-24
Ghosh, R., Bhuiyan, M., Dewan, I., Ghosh, D., and Islam, M. 2012. Immediate release drug delivery system (tablets): An overview. International Research Journal of Pharmaceutical and Applied Sciences. 2(5): 88-94.
Gutierrez-Orozco, F. and Failla, M.L. 2013. Biological activities and bioavailability of mangosteen xanthones: A critical review of the current evidence. Nutrients. 5(8): 3163-3183. https://doi.org/10.3390/nu5083163
Hazlett, R., Schmidmeier, C., and O'Mahony, J.A. 2021. Approaches for improving the flowability of high-protein dairy powders post spray drying - a review. Powder Technology. 388: 26-40. https://doi.org/10.1016/j.powtec.2021.03.021
Herawati, O., Untari, T., Anggita, M., and Artanto, S. 2020. Effect of mangosteen (Garcinia mangostana L.) peel extract as an antibiotic growth promoter on growth performance and antibiotic resistance in broilers. Veterinary World. 13(4): 796-800. https://doi.org/10.14202/vetworld.2020.796-800
Ibrahim, M., Hashim, N., Mariod, A., Mohan, S., Abdulla, M., Abdelwahab, S., and Arbab, I. 2014. α-mangostin from Garcinia mangostana Linn: An updated review of its pharmacological properties. Arabian Journal of Chemistry. 9(3): 317-329. https://doi.org/10.1016/j.arabjc.2014.02.011
Kaewtui, P., Lumsangkul, C., Satsook, A., Sringarm, K., Arjin, C., Tapingkae, W., Khamtavee, P., Srinual, O., Punyatong, M., Huanhong, K., et al. 2024. Initial evaluation of safety and immunomodulatory potential of dietary supplementation with mangosteen pericarp extract for sustainable meat production in native crossbred chickens. Life. 14(11): 1481. https://doi.org/10.3390/life14111481
Karim, N., Shishir, M.R.I., Marappan, G., Khan, S., Hashim, S.B.H., Aalim, H., Arslan, M., Tahir, H.E., Zhihua, L., Zhai, X., et al. 2024. Recent advances in delivering mangosteen-based phytochemicals using promising micro/nanocarriers: Formulation, outcomes, and perspectives. Trends in Food Science & Technology. 153: 104734. https://doi.org/10.1016/j.tifs.2024.104734
Khasanah, H., Kusbianto, D.E., Purnamasari, L., Cruz, J.F.D., Widianingrum, D.C., and Hwang, S.G. 2024. Modulation of chicken gut microbiota for enhanced productivity and health: A review. Veterinary World. 17(5): 1073-1083. https://doi.org/10.14202/vetworld.2024.1073-1083
Le, A.L., Parks, S.E., Nguyen, M.H., and Roach, P.D. 2018. Improving the vanillin-sulphuric acid method for quantifying total saponins. Technologies. 6(3): 84. https://doi.org/10.3390/technologies6030084
Lillehoj, H., Liu, Y., Calsamiglia, S., Fernandez-Miyakawa, M.E., Chi, F., Cravens, R.L., Oh, S., and Gay, C.G. 2018. Phytochemicals as antibiotic alternatives to promote growth and enhance host health. Veterinary Research. 49(1): 76. https://doi.org/10.1186/s13567-018-0562-6
Lin, Y., Lu, M.F., Liao, H.B., Li, Y.X., Han, W., and Yuan, K. 2014. Content determination of the flavonoids in the different parts and different species of Abelmoschus esculentus L. by reversed phase-high performance liquid chromatograph and colorimetric method. Pharmacognosy Magazine. 10(39): 278-284. https://doi.org/10.4103/0973-1296.137368
Lourith, N. and Kanlayavattanakul, M. 2011. Biological activity and stability of mangosteen as a potential natural color. Bioscience, Biotechnology, and Biochemistry. 75(11): 2257-2259. https://doi.org/10.1271/bbb.110521
Majdalawieh, A.F., Khatib, B.K., and Terro, T.M. 2025. Alpha-mangostin is a xanthone derivative from mangosteen with potent immunomodulatory and anti-inflammatory properties. Biomolecules. 15(5): 681. https://doi.org/10.3390/biom15050681
Mazzini, V. and Craig, V.S.J. 2018. Volcano plots emerge from a sea of nonaqueous solvents: The law of matching water affinities extends to all solvents. ACS Central Science. 4(8): 1056-1064. https://doi.org/10.1021/acscentsci.8b00348
Mnisi, C.M., Mlambo, V., Gila, A., Matabane, A.N., Mthiyane, D.M.N., Kumanda, C., Manyeula, F., and Gajana, C.S. 2023. Antioxidant and antimicrobial properties of selected phytogenics for sustainable poultry production. Applied Sciences. 13(1): 99. https://doi.org/10.3390/app13010099
Mohammad, N.A., Abang Zaidel, D.N., Muhamad, I.I., Abdul Hamid, M., Yaakob, H., and Mohd Jusoh, Y.M. 2019. Optimization of the antioxidant-rich xanthone extract from mangosteen (Garcinia mangostana L.) pericarp via microwave-assisted extraction. Heliyon. 5(10): e02571. https://doi.org/10.1016/j.heliyon.2019.e02571
Ngameni, B., Fotso, G.W., Kamga, J., Ambassa, P., Abdou, T., Fankam, A.G., Voukeng, I.K., Ngadjui, B.T., Abegaz, B.M., and Kuete, V. 2013. 9 - flavonoids and related compounds from the medicinal plants of Africa. In: Kuete V., editor. Medicinal plant research in Africa. Oxford: Elsevier. p. 301-350. https://doi.org/10.1016/B978-0-12-405927-6.00009-6
Obianwuna, U.E., Chang, X., Oleforuh-Okoleh, V.U., Onu, P.N., Zhang, H., Qiu, K., and Wu, S. 2024. Phytobiotics in poultry: Revolutionizing broiler chicken nutrition with plant-derived gut health enhancers. Journal of Animal Science and Biotechnology. 15(1): 169. https://doi.org/10.1186/s40104-024-01101-9
Obolskiy, D., Pischel, I., Siriwatanametanon, N., and Heinrich, M. 2009. Garcinia mangostana l.: A phytochemical and pharmacological review. Phytotherapy Research. 23(8): 1047-1065. https://doi.org/10.1002/ptr.2730
Semangoen, T., Chotigawin, R., Sangnim, T., Chailerd, N., Yodkeeree, S., Pahasup-Anan, T., and Huanbutta, K. 2025. Antimicrobial efficacy of mangosteen (Garcinia mangostana) peel extracts in airborne microbial control within livestock farming environments. Microbial Pathogenesis. 204: 107618. https://doi.org/10.1016/j.micpath.2025.107618
Shaji, S., Selvaraj, R.K., and Shanmugasundaram, R. 2023. Salmonella infection in poultry: A review on the pathogen and control strategies. Microorganisms. 11(11): 2814. https://doi.org/10.3390/microorganisms11112814
Shanmugam, S. 2015. Granulation techniques and technologies: Recent progresses. Bioimpacts. 5(1): 55-63. https://doi.org/10.15171/bi.2015.04
Soontornwat, A., Pongsuttiyakorn, T., Rakmae, S., Sritham, E., Sirisomboon, P., Pun, U.K., Krusong, W., and Pornchaloempong, P. 2024. Mangosteen pericarp processing technology to create economic value and reduce biowaste. Foods. 13(14): 2286. https://doi.org/10.3390/foods13142286
Sriboonyong, P., Poommarin, P., Sittiya, J., Opanasopit, P., Ngawhirunpat, T., Patrojanasophon, P., and Pornpitchanarong, C. 2022. The utilization of mangosteen pericarp extract for anticoccidial drug replacement in broiler feed. International Journal of Veterinary Science and Medicine. 10(1): 90-99. https://doi.org/10.1080/23144599.2022.2128271
Sultan, O.S., Kantilal, H.K., Khoo, S.P., Davamani, A.F., Eusufzai, S.Z., Rashid, F., Jamayet, N.B., Soh, J.A., Tan, Y.Y., and Alam, M.K. 2022. The potential of alpha-mangostin from Garcinia mangostana as an effective antimicrobial agent-a systematic review and meta-analysis. Antibiotics. 11(6): 717. https://doi.org/10.3390/antibiotics11060717
Sun, W. and Shahrajabian, M.H. 2023. Therapeutic potential of phenolic compounds in medicinal plants-natural health products for human health. Molecules. 28(4): 1845. https://doi.org/10.3390/molecules28041845
Thiengnoi, P., Suphantharika, M., and Wongkongkatep, P. 2012. Influence of binder type and concentration on physical properties of agglomerated, spray-dried, and high oil loaded microcapsules. Journal of Food, Agriculture and Environment. 10: 141-150.
Van Boeckel, T.P., Brower, C., Gilbert, M., Grenfell, B.T., Levin, S.A., Robinson, T.P., Teillant, A., and Laxminarayan, R. 2015. Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences of the United States of America. 112(18): 5649-5654. https://doi.org/10.1073/pnas.1503141112
Wewers, M., Finke, J.H., Czyz, S., Van Eerdenbrugh, B., John, E., Buch, G., Juhnke, M., Bunjes, H., and Kwade, A. 2022. Evaluation of the formulation parameter-dependent redispersibility of API nanoparticles from fluid bed granules. Pharmaceutics. 14(8): 1688. https://doi.org/10.3390/pharmaceutics14081688
World Health Organization. 2011. Quality control methods for herbal materials. Geneva: World Health Organization.
Yazarlu, O., Iranshahi, M., Ishida, S., Reshadat, S., Habtemariam, S., Iranshahy, M., and Hasanpour, M. 2021. Perspective on the application of medicinal plants and natural products in wound healing: A mechanistic review. Pharmacological Research. 174: 105841. https://doi.org/10.1016/j.phrs.2021.105841
Yuvanatemiya, V., Srean, P., Klangbud, W.K., Venkatachalam, K., Wongsa, J., Parametthanuwat, T., and Charoenphun, N. 2022. A review of the influence of various extraction techniques and the biological effects of the xanthones from mangosteen (Garcinia mangostana L.) pericarps. Molecules. 27(24): 8775. https://doi.org/10.3390/molecules27248775
Zhu, J., Liu, Q., Wang, Y., Zhu, K., Guo, J., Jin, Y., and Liu, Y. 2024. Mangosteen extract reduces the bacterial load of eggshell and improves egg quality. Heliyon. 10(15): e35857. https://doi.org/10.1016/j.heliyon.2024.e35857
OPEN access freely available online
Natural and Life Sciences Communications
Chiang Mai University, Thailand. https://cmuj.cmu.ac.th
Prasopchai Patrojanasophon1, 2, Nitjawan Sahatsapan1, 3, Supusson Pengnam1, 2, Boonnada Pamornpathomkul1, 2, Thapakorn Charoenying1, 2, Tanasait Ngawhirunpat1, 2, Theerasak Rojanarata1, 2, Praneet Opanasopit1, 2, and Chaiyakarn Pornpitchanarong1, 2, *
1 Pharmaceutical Development of Green Innovations Group (PDGIG), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
2 Research and Innovation Center for Advanced Therapy Medicinal Products, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
3 Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague 160 00, Czech Republic.
Corresponding author: Chaiyakarn Pornpitchanarong, E-mail: pornpitchanaron_c@su.ac.th
ORCID iD:
Prasopchai Patrojanasophon: https://orcid.org/0000-0002-4974-4532
Nitjawan Sahatsapan: https://orcid.org/0009-0006-2760-7007
Supusson Pengnam: https://orcid.org/0000-0003-4664-0276
Boonnada Pamornpathomkul: https://orcid.org/0000-0002-1354-2648
Thapakorn Charoenying: https://orcid.org/0000-0003-2419-1676
Tanasait Ngawhirunpat: https://orcid.org/0000-0003-4260-6097
Theerasak Rojanarata: https://orcid.org/0000-0002-5309-1896
Praneet Opanasopit: https://orcid.org/0000-0002-4878-2529
Chaiyakarn Pornpitchanarong: https://orcid.org/0000-0001-6540-280X
Total Article Views
Editor: Dr. Sirasit Srinuanpan,
Chiang Mai University, Thailand
Article history:
Received: March 12, 2026;
Revised: July 31, 2026;
Accepted: October 26, 2026;
Online First: November 19, 2026